Freely Filtered, a NephJC Podcast

Advertise on podcast: Freely Filtered, a NephJC Podcast

Rating
4.9
from
155 reviews
This podcast has
65 episodes
Language
Publisher
Explicit
No
Date created
2019/04/27
Average duration
79 min.
Release period
35 days

Description

Twice monthly (aspirational) recap of the NephJC journal club. NephJC reviews the most important manuscripts which are driving nephrology forward and improving our understanding of the kidney.

Social media

Check Freely Filtered, a NephJC Podcast social media presence


Podcast episodes

Check latest episodes from Freely Filtered, a NephJC Podcast podcast


Freely Filtered 065: BEST Fluids
2024/02/10
The fluids wars have been going back and forth and now have another big win. This time in transplant.
FF 64 Kidney Week Live
2023/11/12
On Friday of #KidneyWk, at the City Winery in Philadelphia, The Filtrate collaborated with The Curbsiders to do a live show in front of dozens of fans. Freely Filtered is proud to get to play a role in one of these moments. Amit Garg, friend of the Pod, invited Freely Filtered into the tent to record a podcast on his High Impact and Late Breaking Clinical Trial for simultaneous release with his presentation. Here is that podcast… How do we move the needle on living donor transplants? The EnAKT LKD Cluster Randomized Clinical Trial takes its shot
more
Freely Filtered 63: Late Breaking and High Impact Clinical Trials
2023/11/03
We love Kidney Week and the quintessential event at Kidney Week is the Late Break and High Impact Clinical Trial Sessions. Here we see the cutting edge of science revealed. We get to be first when years of work are revealed to the world. And one of the coolest ways for a study to be revealed is with simultaneous publication in a high-impact journal. Freely Filtered is proud to get to play a role in one of these moments. Amit Garg, friend of the Pod, invited Freely Filtered into the tent to record a podcast on his High Impact and Late Breaking Clinical Trial for simultaneous release with his presentation. Here is that podcast… How do we move the needle on living donor transplants? The EnAKT LKD Cluster Randomized Clinical Trial takes its shot
more
Freely Filtered 62: Inaxaplin for APOL1 Kidney Disease
2023/09/25
Inaxaplin is a small molecule that is in trials for APOL1 associated kidney disease. Genome guided medicine comes to nephrology.
Freely Filtered 061: Bicarbonate in Transplant
2023/09/24
Bicarbonate did not slow the loss of GFR in this well done Swiss, single-blind study of transplant patients. The Filtrate: Joel Topf Nayan Arora Swapnil Hiremath Pirya Yenebere With Special Guest: Nav Tangri nephrologist and epidemiology at the University of Manitoba Editor: Nayan Arora Show Notes: Arsenal FC The London study that kicked it all off! de Brito-Ashurst, I., Varagunam, M., Raftery, M. J., & Yaqoob, M. M. (2009). Bicarbonate supplementation slows progression of CKD and improves nutritional status. Journal of the American Society of Nephrology: JASN, 20(9), 2075–2084. The multi center (but unblinded) UBI Study with mortality benefit! Di Iorio, B. R., Bellasi, A., Raphael, K. L., Santoro, D., Aucella, F., Garofano, L., Ceccarelli, M., Di Lullo, L., Capolongo, G., Di Iorio, M., Guastaferro, P., Capasso, G., & UBI Study Group. (2019). Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study. Journal of Nephrology, 32(6), 989–1001. The BiCARB Study: Double blinded and negative BiCARB study group. (2020). Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial. BMC Medicine, 18(1), 91. The initial Veverimer Study Wesson, D. E., Mathur, V., Tangri, N., Stasiv, Y., Parsell, D., Li, E., Klaerner, G., & Bushinsky, D. A. (2019). Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension. In The Lancet (Vol. 394, Issue 10196, pp. 396–406). doi.org/10.1016/s0140-6736(19)31388-1 The Valor CKD trial is still unpublished. But here is the press release. VALOR-CKD design manuscript The study of the night: Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomized, single-blind, placebo-controlled, phase 3 trial NephJC | PubMed | Lancet Alkali with normal bicarb? Sure, take a look at: Goraya, N., Simoni, J., Jo, C., & Wesson, D. E. (2012). Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney International, 81(1), 86–93. Metforminator! The BASE Trial: Raphael, K. L., Isakova, T., Ix, J. H., Raj, D. S., Wolf, M., Fried, L. F., Gassman, J. J., Kendrick, C., Larive, B., Flessner, M. F., Mendley, S. R., Hostetter, T. H., Block, G. A., Li, P., Middleton, J. P., Sprague, S. M., Wesson, D. E., & Cheung, A. K. (2020). A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial. Journal of the American Society of Nephrology: JASN, 31(1), 161–174. Tubular Secretions Swap The Three-Body Problem (novel) | Netflix Nayan Women’s World Cup Tangri English Premier Soccer and Inflation Priya Silo on Apple TV Joel Live Podcast recording at ASN Kidney
more
Freely Filtered 09: Torsemide v Furosemide
2023/07/03
Another dogma shredding trial about diuretics, this time torsemide goes up against king furosemide and its ability to prevent rehospitalization and CV events.
Freely Filtered 060: HCTZ v Stones. The NOSTONE Trial
2023/06/25
Another dogma shredding trial about diuretics, this time hydrochlorothiazide ability to reduce symptomatic kidney stone events and kidney stone growth gets put under the knife.
Freely Filtered 058: HCTZ v Chlorthalidone, The Diuretic Comparison Project
2023/05/02
The diuretic comparison project is a large, well done, pragmatic trial, that puts to rest the debate of HCTZ versus chlorthalidone. Listen to the Filtrate wrestle with their own cognitive dissonance.
more
Freely Filtered 057: NephMadness TMA
2023/03/11
Welcome to the NephMadness PodCrawl The idea behind a podcrawl is for a variety of podcasts to coordinate on timing and topic to push a theme and get each other’s listeners to explore all of the podcasts. One of the first goals behind NephMadness was to build a community and in the early years of Twitter, NephMadness was central to the formation of #NephTwitter and defining the ethos that makes our online community kind, intelligent, vibrant, and interesting. The NephMadness Podcrawl hopes to inspire and grow the nephrology podcast community in the same way. For 2023, our second year,  the PodCrawl has assembled the Avengers of Medical Pods! * The Curbsiders gets the skinny on mineralcorticoid receptor antagonists * Core IM will be covering Kidney Transplant in their classic Five Pearl format * The CardioNerds will be covering the effect of Heart Failure Devices on Kidney Health * Freely Filtered will try to understand thrombotic microangiopathy * ISN Global Kidney Care goes deep on IgA nephropathy * The Cribsiders look at transitions, first the Peditrics to Adult nephrology transition and then from living to death with palliative nephrology  * Fellow on Call will be covering Onconephrology * And finally, The Nephron Segment looks at Transgender Health and CKD 8 podcasts. 1 for each region in this year’s NephMadness   Go to NephMadness.com/podcrawl to get links to all of the shows.
more
NephMadness PodCrawl 2023
2023/03/01
Welcome to the NephMadness PodCrawl The idea behind a podcrawl is for a variety of podcasts to coordinate on timing and topic to push a theme and get each other’s listeners to explore all of the podcasts. One of the first goals behind NephMadness was to build a community and in the early years of Twitter, NephMadness was central to the formation of #NephTwitter and defining the ethos that makes our online community kind, intelligent, vibrant, and interesting. The NephMadness Podcrawl hopes to inspire and grow the nephrology podcast community in the same way. For 2023, our second year,  the PodCrawl has assembled the Avengers of Medical Pods! Go to NephMadness.com/podcrawl for more information and links to all of the podcasts!The Curbsiders gets the skinny on mineralcorticoid receptor antagonists Core IM will be covering Kidney Transplant in their classic Five Pearl format The CardioNerds will be covering the effect of Heart Failure Devices on Kidney Health Freely Filtered will try to understand thrombotic microangiopathy ISN Global Kidney Care goes deep on IgA nephropathy The Cribsiders look at transitions, first the Peditrics to Adult nephrology transition and then from living to death with palliative nephrology  Fellow on Call will be covering Onconephrology And finally, The Nephron Segment looks at Transgender Health and CKD
more
Freely Filtered 056: MYTEMP
2023/02/07
MYTEMP is the largest dialysis trial. 15000 patients, 4.3 million dialysis treatments. We bring in lead PI Amit Garg to help break it down the trial and its implications.
Freely Filtered 055: STOP-ACE
2023/01/29
For years there has been a growing dogma that if you stop the Renin Angiotensin inhibition when the GFR gets low you can delay dialysis. STOP ACE put the dogma to the test. The results are...meh.
more

Podcast reviews

Read Freely Filtered, a NephJC Podcast podcast reviews


4.9 out of 5
155 reviews
Rdswinford 2023/03/11
⭐️⭐️⭐️⭐️⭐️
Great topic. But 24-hr turnaround with MACHEON labs and University of Cincinnati. DOn’t wait two weeks. But even if negative 30-40% still can have gen...
more
Impact Factor 2022/10/12
Amazing
I listen to every podcast - great balance of methods, renal phys, and jokes
Originalroc 2022/06/30
My favorite podcast
This is my favorite Nephrology podcast and a constant source of inspiration and learning!! I love listening to all the members of the podcast. Thank y...
more
AnotherListener3 2022/07/14
Interesting Idea...
I don't like journal clubs. So the idea of listening to one voluntarily does not come naturally. A member of my nephrology group recommended Freely ...
more
drjmac5 2022/06/30
Perfect Keeping up with Relevant Clinical Nephrology
I’m a nephrologist in private practice. I have very little free time but do the best I can like most doctors to keep up with journal articles as they ...
more
Gregory Keith Monroe Jr. 2022/06/30
One of best clinical podcasts
Any subject
BenStone3350 2022/02/06
Amazing
As a nephrology fellow, I listen to this podcast every day while I’m driving to work and back. I learn something new every day!
Sodagum 2022/01/13
Nephrologist
For a solo private practitioner who hardly gets time to review, this is an awesome educational podcast. I listen to it while driving to different hos...
more
Kidney (not renal) admirer 2021/12/07
STILL Love this podcast!
These are also fun to listen a second time! Just feels like hanging out with friends. one episode is better than the next! I love how it is conversati...
more
annoyed and angry ^2 2021/11/10
Amazing, entertaining
Love the podcast. Great group of experts. I will not stop saying RENAL though! Lol Would love if can have a series on general nephrology review topic...
more
check all reviews on aple podcasts

Podcast sponsorship advertising

Start advertising on Freely Filtered, a NephJC Podcast & sponsor relevant audience podcasts


What do you want to advertise?

Ad Format

Campaign Budget

Business Details